Financial Summary -
Endocrin Diagnostic Si Tratament S.r.l.
Unique identification code:7713958
Registration number:J05/1300/1995
Nace:8622
Sales - Ron
120.601
Net Profit - Ron
18.585
Employees
4
Open Account
Company Endocrin Diagnostic Si Tratament S.r.l. with Fiscal Code 7713958
recorded a turnover of 2024 of
120.601,
with a net profit of
18.585
and having an average number of employees of
4.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Endocrin Diagnostic Si Tratament S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
23.477
47.258
41.889
36.415
57.439
45.082
33.216
61.147
83.882
120.601
Total Income - EUR
23.477
47.258
41.889
36.415
57.439
46.163
33.216
61.148
83.884
120.822
Total Expenses - EUR
34.231
32.465
34.868
36.585
38.499
33.205
38.774
47.831
77.169
98.685
Gross Profit/Loss - EUR
-10.754
14.793
7.021
-170
18.940
12.958
-5.558
13.317
6.714
22.137
Net Profit/Loss - EUR
-11.458
14.320
6.602
-535
18.366
12.526
-5.797
12.718
6.001
18.585
Employees
4
4
3
3
4
2
3
3
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 44.6%, from 83.882 euro in the year 2023, to 120.601 euro in 2024.
The Net Profit increased by 12.617 euro, from 6.001 euro in 2023, to 18.585 in the last year.
Check the financial reports for the company - Endocrin Diagnostic Si Tratament S.r.l.
Financial Rating - ENDOCRIN DIAGNOSTIC SI TRATAMENT...
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Endocrin Diagnostic Si Tratament...
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Endocrin Diagnostic Si Tratament...
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Endocrin Diagnostic Si Tratament...
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Endocrin Diagnostic Si Tratament S.r.l. - CUI 7713958
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
1.732
929
317
1.085
938
1.968
1.373
825
414
1.354
Current Assets
423
666
716
1.394
7.217
17.727
9.670
15.070
22.881
27.065
Inventories
0
0
0
75
0
0
0
0
340
16
Receivables
118
102
344
395
1.622
2.654
443
452
1.946
3.444
Cash
306
564
372
925
5.595
15.073
9.227
14.618
20.594
23.605
Shareholders Funds
-34.946
-20.269
-13.323
-13.613
5.016
17.446
5.703
12.767
18.729
18.633
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
37.101
21.863
14.356
16.093
3.139
2.249
5.340
3.128
4.566
9.786
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
27.065 euro in 2024 which includes Inventories of
16 euro, Receivables of
3.444 euro and cash availability of
23.605 euro.
The company's Equity was valued at
18.633 euro, while total Liabilities amounted to
9.786 euro.
Equity increased by 8 euro, from 18.729 euro in 2023, to 18.633 in 2024.
Comments - Endocrin Diagnostic Si Tratament S.r.l.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Endocrin Diagnostic Si Tratament S.r.l.